VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
INNV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
INNVInnovAge Holding Corp.
$8.91$1.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksINNVP/E History

INNV logoInnovAge Holding Corp. (INNV) P/E Ratio History

Fairly Valued

Trading at 135.8x, near 5Y avg of 125.7x · 40th percentile · In line with own history · Data 2021–2027

Current P/E (TTM)
135.8x
+8% vs 5Y avg
5Y Avg P/E
125.7x
Median 152.0x
5Y Percentile
40th
Mid-range
PEG Ratio
N/A
5-Year P/E Range
135.8x
Min64.2xMedian152.0xMax174.4x
TTM EPS$0.07
Price$8.91
Earnings Yield0.74%
EPS Growth (1Y)91.5%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of November 19, 2026, InnovAge Holding Corp. (INNV) trades at a price-to-earnings ratio of 135.8x, with a stock price of $8.91 and trailing twelve-month earnings per share of $0.07.

The current P/E is roughly in line with its 5-year average of 125.7x. Over the past five years, INNV's P/E has ranged from a low of 64.2x to a high of 174.4x, placing the current valuation at the 40th percentile of its historical range.

Compared to the Healthcare sector median P/E of 24.7x, INNV trades at a 451% premium to its sector peers. The sector includes 252 companies with P/E ratios ranging from 0.0x to 187.0x.

Relative to the broader market, INNV commands a significant premium over the S&P 500 median P/E of 21.7x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our INNV DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

INNV Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
135.8vs24.7
+451%
Above Sector
vs. S&P 500
135.8vs21.7
+526%
Above Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 92% EPS growth (1Y)

INNV P/E vs Peers

Post-Acute & Senior Care peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
ALHC logoALHCAlignment Healthcare, Inc.
$1B48.4-+99%
OSCR logoOSCROscar Health, Inc.
$7B11.2--1866%
ENSG logoENSGThe Ensign Group, Inc.
$11B27.21.97Best+14%
UNH logoUNHUnitedHealth Group Incorporated
$318B19.9--15%
HUM logoHUMHumana Inc.
$46B37.8--1%
CVS logoCVSCVS Health Corp.
$104B9.5Lowest--62%
CNC logoCNCCentene Corp.
$33B22.8--316%
WELL logoWELLWelltower Inc.
$178B127.7--11%
VTR logoVTRVentas, Inc.
$43B172.3-+184%Best

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

INNV Historical P/E Data (2021–2027)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2027 Q1Sep 30 2026$8.80$0.06152.0x+21%
FY2022 Q3-$6.42$0.1064.2x-49%
FY2022 Q2Dec 31 2021$5.00$0.03166.7x+33%
FY2022 Q1-$6.61$0.0971.2x-43%
FY2021 Q4Jun 30 2021$21.31$0.12174.4x+39%

Average P/E for displayed period: 125.7x

Export Data
Consensus & Technical Research Suite
Open INNV Terminal

INNV Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

5+ years return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

INNV — Frequently Asked Questions

Quick answers to the most common questions about buying INNV stock.

What is INNV's P/E ratio?

InnovAge Holding Corp. (INNV) trailing twelve-month P/E ratio is 135.8x, based on TTM diluted EPS of $0.07. The 5-year average P/E is 125.7x and the historical range spans 64.2x to 174.4x.

Is INNV stock overvalued or undervalued?

INNV trades at 135.8x P/E, near its 5-year average of 125.7x. The 40th percentile ranking within the 64.2x–174.4x historical range places valuation within normal bounds.

Is INNV stock expensive?

INNV is fairly valued relative to its own history. The current P/E of 135.8x is near the 5-year average of 125.7x (40th percentile of historical range).

What is INNV's historical P/E range?

Over the past 5 years, INNV's P/E ratio has ranged from 64.2x to 174.4x, with a median of 152.0x and an average of 125.7x. The current P/E of 135.8x places the stock at the 40th percentile of this range. Full historical data spans 2021–2027.

How does INNV's P/E compare to the S&P 500?

INNV trades at 135.8x P/E versus the S&P 500 median of 21.7x. The 526% premium to the market typically reflects higher expected earnings growth or quality.

How does INNV's valuation compare to Healthcare peers?

InnovAge Holding Corp. P/E of 135.8x compares to the Healthcare sector median of 24.7x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is INNV's PEG ratio?

INNV PEG ratio is N/A, based on a P/E of 135.8x and EPS growth of 91.5%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is INNV's earnings yield?

INNV earnings yield is 0.74%, the inverse of its 135.8x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

INNV P/E Ratio History (2021–2027)

Quarterly valuation multiple from closing price and trailing EPS

Current152.0x
Period Avg125.7x
Range64.2x - 174.4x
Change-13%
5 quartersJun 30, 2021 - Sep 30, 2026